Max Healthcare Institute Limited (NSE:MAXHEALTH)
India · Delayed Price · Currency is INR | Market Cap | 1.11T |
| Revenue (ttm) | 75.13B |
| Net Income (ttm) | 11.48B |
| Shares Out | n/a |
| EPS (ttm) | 11.74 |
| PE Ratio | 96.91 |
| Forward PE | 59.20 |
| Dividend | 1.50 (0.13%) |
| Ex-Dividend Date | Jul 4, 2025 |
| Volume | 3,169,541 |
| Average Volume | 6,207,861 |
| Open | 1,130.00 |
| Previous Close | 1,130.70 |
| Day's Range | 1,128.00 - 1,147.40 |
| 52-Week Range | 888.90 - 1,314.30 |
| Beta | 0.25 |
| RSI | 48.42 |
| Earnings Date | Nov 4, 2025 |
About Max Healthcare Institute
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness service... [Read more]
Financial Performance
In 2024, Max Healthcare Institute's revenue was 70.28 billion, an increase of 30.01% compared to the previous year's 54.06 billion. Earnings were 10.76 billion, an increase of 1.72%.
Financial StatementsNews
Nifty top gainers today, October 8: Titan Company, Infosys, TCS, HCL Technologies, Max Healthcare and more
Indian benchmark indices ended lower on October 8, with Nifty closing at 25,046.15, down 62.15 points, and Sensex slipping 153.09...
Nifty top gainers today, October 6: Max Healthcare, Shriram Finance, TCS, Tech Mahindra, Apollo Hospitals and more
Indian equity markets closed higher on October 6, with the Nifty crossing the 25,000 mark. The Sensex ended at 81,790.12,...
Why are Max Healthcare shares up nearly 3% today? Explained
Shares of Max Healthcare Institute Ltd surged nearly 3% in Monday’s session, trading at Rs 1,101 as of 9:07 AM....
Nifty top losers this week (ending October 3): Max Healthcare, Maruti Suzuki India, Eicher Motors, Coal India and more
The Indian equity market ended the first week of October on a positive note, with benchmark indices recording steady gains....
Nifty 50 top losers today, October 3: Max Healthcare, Tech Mahindra, Eicher Motors, Coal India, Maruti Suzuki India and more
Indian benchmark indices closed higher on October 3, with the Nifty touching 24,900, while the Sensex rose 223.86 points, or...
InterGlobe Aviation shares fall 3% as stock debuts on Nifty 50
Shares of InterGlobe Aviation Ltd., parent company of Indigo airlines, slipped nearly 3% in early trade on Tuesday, September 30, as the stock began trading as a Nifty 50 constituent. The decline came...
Max Health and Interglobe Aviation to enter Nifty 50 index, Hero MotoCorp and IndusInd Bank out
The National Stock Exchange has announced changes to its flagship Nifty 50 index, which will take effect from the close of trading on September 29, 2025. Max Healthcare and InterGlobe Aviation are set...
Jefferies advises to buy Max Healthcare with Rs 1,500 target price, cites growth momentum and expansion plans
Jefferies has maintained its buy rating on Max Healthcare with a target price of ₹1,500 after the hospital operator delivered a mixed set of first-quarter results. Revenue came in ahead of estimates, ...
Stocks to watch on August 18: M&M, Ashok Leyland, Tata Chemicals, HDFC Bank, BPCL, Max Healthcare and more
Brokerage houses have released fresh updates and recommendations on key Indian stocks and sectors, which are likely to drive trading action today. Here are the highlights from fund house recommendatio...
Max Healthcare Q1 Results: Net revenue jumps 27% YoY to Rs 2,460 crore, net profit up 17% YoY
Max Healthcare Institute Ltd. (MHIL) reported strong Q1 FY26 results with network gross revenue at ₹2,574 crore, up 27% YoY and 6% QoQ, led by higher outpatient volumes. International patient revenue ...
Max Healthcare shares jump 3% as Jefferies reaffirms bullish outlook despite regulatory concerns
Max Healthcare shares climbed 3% in Monday’s trade, even as the broader hospital sector faced pressure over concerns of tighter regulations on health insurance claims. A recent media report suggested ...
Hospital stocks under pressure on regulatory fears, but Jefferies remains bullish on Max Healthcare and Fortis
Hospital stocks came under selling pressure after a media report suggested that the Government of India may soon introduce measures to regulate health insurance claims more tightly. The move is report...
Stocks hitting 52-week highs today, June 16: Bharat Electronics, Laurus Labs, Max Healthcare, JK Cement and more
Indian equity markets closed on a positive note on June 16, 2025, as benchmark indices posted strong gains across the board. The BSE Sensex surged 677.55 points (0.84%) to close at 81,796.15, while th...
Max Healthcare shares jump 2% after Jefferies maintains ‘Buy’ call with target price of Rs 1,400
Max Healthcare shares rose 2% in morning trade after global brokerage Jefferies reiterated its “Buy” rating on the stock with a target price of ₹1,400. The positive sentiment stems from Max Healthcare...
Stocks to watch on June 12: Tata Comm, Max Health, Dr Reddy’s, HDFC Life, PayTM in focus on brokerage views
Several brokerages have released their latest views and price targets on key listed companies. Here are the highlights of fund house recommendations for the day: CLSA on Tata Communications: Maintain ...
Jefferies maintains ‘Buy’ call on Max Healthcare; sees 75% bed capacity expansion as key growth driver
Jefferies has reiterated a Buy rating on Max Healthcare Institute, assigning a target price of ₹1,400, citing strong expansion plans and a proven execution record. The company is set to expand its tot...
Brokerages on Max Healthcare stock: Buy, sell or hold? Check UBS, HSBC calls
Max Healthcare is in focus following its Q4 FY25 results, with brokerages offering mixed views on the stock. While UBS turned more bullish, raising its target price to Rs 1,350 and reiterating a buy c...
HSBC maintains ‘Hold’ on Max Healthcare; sees 7.8% downside amid limited re-rating scope
HSBC has maintained a ‘Hold’ rating on Max Healthcare Institute Ltd, assigning a target price of ₹1,055, which implies a 7.8% downside from the current market price of ₹1,144 (as of latest close). The...
UBS maintains ‘Buy’ on Max Healthcare, raises target price; sees 18% upside amid expansion-led growth
UBS has maintained its ‘Buy’ rating on Max Healthcare Institute Ltd, while raising the target price to ₹1,350, implying an upside of 18% from the current market price of ₹1,144.00 (as of latest close)...
Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus
Several companies are likely to remain in focus today owing to key regulatory updates, project wins, acquisitions, and strategic corporate announcements. Dr Reddy’s Laboratories received two observati...
Pharma and healthcare stocks: Macquarie turns bullish on Sun Pharma, Cipla, Lupin; bearish on Apollo Hospitals, Max Healthcare
Macquarie believes the recent correction in pharmaceutical formulation stocks triggered by tariff-related concerns presents a compelling buying opportunity. In its latest sector note, the brokerage ha...
Max Healthcare unit merger aims at improved cash flow and reduced compliance burden
Crosslay Remedies to merge into Jaypee Healthcare as part of Max Healthcare restructuring.
Max Healthcare to enter long-term service agreement for New Delhi Hospital
Max Healthcare Institute Limited has announced its board’s approval to enter into a Long-term Service Agreement (LTSA) with Bharat Prakritik Chikitsa Mission (BPCM) for a 200-bedded hospital in Pitamp...
Top stocks to buy: Stock recommendations for the week starting March 3
Stock market recommendations: Motilal Oswal Financial Services Ltd recommends HDFC Bank and Max Healthcare for this week. HDFC Bank is set to benefit from RBI's new policies Max Healthcare shows signi...
Max Healthcare shares surge 2% as UBS upgrades to ‘Buy’ rating with target price of Rs 1,200
Max Healthcare shares jumped 2% after UBS upgraded the stock to ‘Buy’ from ‘Neutral’ and raised its target price to ₹1,200. As of 9:39 AM, the shares were trading 1.63% higher at Rs 1,031.20. The brok...